文献速递妇科

子宫内膜癌子宫切除术患者结局及住院90天费用相关因素——对打包付费的启示

Factors associated with outcomes and inpatient 90-day cost of care in endometrial cancer patients undergoing hysterectomy - implications for bundled care payments.
PubMed 文献 · Gynecol Oncol · 2018-01-01

基于2013年美国再入院数据库27,658例子宫内膜癌子宫切除术患者,分析肥胖及合并症与术后结局和30天、90天住院费用的关联。III度肥胖较非肥胖患者医疗并发症和30天再入院率更高、费用更高,合并症数量显著影响费用与结局。作者建议打包付费应依据地区与医院类型的肥胖率和医疗合并症进行调整。

要点

  • III度肥胖患者医疗并发症22.3% vs 非肥胖17.2%(p=0.004)。
  • III度肥胖患者30天再入院率6% vs 非肥胖4.4%(p=0.003)。
  • III度肥胖(OR 1.1,95%CI 1.1-1.18)与I/II度肥胖(OR 1.05,95%CI 1.02-1.09)均与更高费用相关。

核心结论

  • 与非肥胖人群相比,III度肥胖与更高的医疗(非手术)并发症发生率和更高的总体住院费用相关,但手术并发症率相似。
  • 合并症数量显著影响子宫切除术后费用和结局。
  • 作者认为,随着更多医疗举措关注打包付费,付费方案应按地区和医院类型对肥胖率和医疗合并症进行调整,以公平补偿增加的医疗费用。

研究设计与样本

  • 基于2013年美国再入院数据库(National Readmission Database)的回顾性分析,纳入接受子宫切除术的子宫内膜癌患者27,658例。
  • 肥胖分类:非肥胖(BMI<35 kg/m²);I/II度肥胖(BMI≥35且<40 kg/m²,且无符合病态肥胖定义的肥胖相关疾病);III度肥胖(BMI≥40 kg/m²,或BMI≥35 kg/m²且伴有肥胖相关疾病)。
  • 采用费用-收费比计算30天和90天增量费用。

主要发现

  • III度肥胖患者任何医疗(非手术)并发症发生率22.3% vs 非肥胖17.2%(p=0.004),30天再入院率6% vs 4.4%(p=0.003),手术并发症率相似。
  • 非肥胖患者与传统腹腔镜率8.4% vs III度肥胖13.6%(p<0.001),微创转开腹率5.5% vs 8.2%(p<0.001)。
  • 多因素回归显示,与非肥胖患者相比,I/II度肥胖(OR 1.05,95%CI 1.02-1.09)和III度肥胖(OR 1.1,95%CI 1.1-1.18)与更高费用相关。
  • 其他增加费用的因素包括:合并症评分每增加1单位(OR 1.08,95%CI 1.07-1.08)、保险状态和手术路径。
  • 非肥胖与I/II度肥胖患者围手术期结局无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the association of obesity and other comorbidities as well as route of surgery with postoperative outcomes, as well as 30- and 90-day inpatient cost of care after hysterectomy for endometrial cancer. METHODS: From the 2013 National Readmission Database release, patients who underwent hysterectomy for endometrial cancer were included. Obesity was classified as non-obese (body mass index [BMI] < 35 kg/m2); class I/II obesity (BMI ≥ 35 but <40 kg/m2 and without obesity related medical condition qualifying it as morbid obesity), class III obesity (BMI ≥ 40 kg/m2 OR BMI ≥ 35 kg/m2 with an obesity-related medical condition). Incremental cost at 30 and 90 days was calculated using cost-to-charge ratio. RESULTS: A total of 27,658 patients were identified. Compared to non-obese patients those with class III obesity had higher rate of any medical (non-surgical) complication (22.3% vs 17.2%, p = 0.004), and higher rate of 30-day readmission (6% vs 4.4%, p = 0.003), but similar rates of surgical complications. There were no significant differences in perioperative outcomes between non-obese patients and those with class I/II obesity. Non-obese patients had higher rates of traditional laparoscopy (8.4% vs 13.6%, p < 0.001) and lower conversion rates from a minimally invasive to abdominal (5.5% vs. 8.2%, p < 0.001) than those with class III obesity. Based on multivariate regression model compared to non-obese patients, class I/II obesity (OR 1.05, 95% CI 1.02-1.09) and class III obesity (OR 1.1, 95% CI 1.1-1.18) were associated with higher cost of care. Other factors increasing cost of care included: comorbidity score per unit increase (OR 1.08, 95% 1.07-1.08), insurance status and route of surgery. CONCLUSIONS: Class III obesity was associated with higher medical (but not surgical) complication rates as well as increased overall inpatient care cost when compared to the non-obese population. Number of comorbidities significantly impacted the cost and outcomes after hysterectomy. As more healthcare initiatives focus on bundled payments, our results suggest that payment packages should adjust for obesity rates and medical comorbidities stratified by region and hospital type in order to fairly compensate for increased costs of care.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Rolston A, Spencer RJ, Kevin Reynolds R, et al. Factors associated with outcomes and inpatient 90-day cost of care in endometrial cancer patients undergoing hysterectomy - implications for bundled care payments. Gynecol Oncol. 2018. PMID: 29778507. doi:10.1016/j.ygyno.2018.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。